Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free TCRX Stock Alerts

TScan Therapeutics (TCRX) Earnings Date, Estimates & Call Transcripts

TScan Therapeutics logo
$1.26 +0.05 (+4.13%)
Closing price 04:00 PM Eastern
Extended Trading
$1.27 +0.01 (+0.71%)
As of 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

TScan Therapeutics Earnings Summary

TScan Therapeutics announced Q1 2026 earnings on May 6, 2026, reporting an EPS of -$0.22, which met the consensus estimate of -$0.22. Quarterly revenue was reported to be $0.98 million, below analysts' expectations of $2.50 million. With a trailing EPS of -$1.00, TScan Therapeutics' earnings are expected to grow next year, from ($1.02) to ($0.94) per share.

Latest Q1
Earnings Date
May. 6Estimated
Consensus EPS
(May. 6)
-$0.22
Actual EPS
(May. 6)
-$0.22
Actual Revenue
(May. 6)
$0.98M

Q1 2026 Earnings Resources

Powered by Quartr
Get TScan Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TScan Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TCRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TCRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

TScan Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.17-$0.16-$0.17
Q2 20262-$0.21-$0.18-$0.20
Q3 20262-$0.22-$0.18-$0.20
Q4 20262-$0.23-$0.18-$0.21

TScan Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026-$0.22-$0.22--$0.22$2.50M$0.98M
3/4/2026Q4 2025-$0.27-$0.18+$0.09-$0.18$2.44M$2.57M
11/12/2025Q3 2025-$0.35-$0.28+$0.07-$0.28$1.98M$2.51M
8/12/2025Q2 2025-$0.28-$0.2848 -$0.0048-$0.28$1.31M$3.08M
5/12/2025Q1 2025-$0.28-$0.26+$0.02-$0.26$1.62M$2.17M
3/5/2025Q4 2024-$0.27-$0.29 -$0.02-$0.30$1.43M$0.67M
11/12/2024--$0.28-$0.25+$0.03-$0.25$2.86M$1.05M
8/12/2024--$0.30-$0.28+$0.02-$0.28$1.55M$0.54M
5/13/2024Q1 2024-$0.25-$0.32 -$0.07-$0.32$3.75M$0.57M

Data powered by Fiscal.ai.

TScan Therapeutics Earnings - Frequently Asked Questions

TScan Therapeutics (NASDAQ:TCRX) last announced its quarterly earning data on Wednesday, May 6, 2026. Learn more on TCRX's earnings history.

In the previous quarter, TScan Therapeutics (NASDAQ:TCRX) reported ($0.22) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.22). Learn more on analysts' earnings estimate vs. TCRX's actual earnings.

TScan Therapeutics (NASDAQ:TCRX) has a recorded annual revenue of $10.32 million.

TScan Therapeutics (NASDAQ:TCRX) has a recorded net income of -$129.77 million. TCRX has generated -$1.00 earnings per share over the last four quarters.

TScan Therapeutics' earnings are expected to grow from ($1.02) per share to ($0.94) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:TCRX) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
The Death of the Nasdaq?
The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...
Chaikin Analytics | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
The Iran War Just Broke the Gold Market
The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...
Behind the Markets | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Elon’s “XG” Coming for $2 TRILLION Market?
SpaceX has announced plans to go public at a projected $1.5 trillion valuation - potentially 58 times larger t...
Paradigm Press | Sponsoredtc pixel
This Biotech Just Flipped From Story to Execution
Avai Bio, Inc. (OTCQB: AVAI) has launched production of its new Master Cell Bank alongside Austrianova, markin...
Equiscreen | Sponsoredtc pixel